Scandal-prone Subsys maker Insys falls as auditor flags going concern doubt

After hiring Lazard in the fourth quarter for counsel on capital planning and strategic alternatives, the auditor of the controversial opioid painkiller maker Insys Therapeutics has raised doubts on the drugmaker’s ability to continue as a going concern.